You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non Small Cell Lung Cancer Metastatic

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy

Not yet recruiting
  • Non-small Cell Lung Cancer Metastatic
    • (no location specified)
    Sep 13, 2023

    Non Small Cell Lung Cancer Metastatic Trial (MRI)

    Not yet recruiting
    • Non Small Cell Lung Cancer Metastatic
    • MRI
    • (no location specified)
    May 16, 2023

    Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)

    Recruiting
    • Cancer
    • +11 more
    • San Antonio, Texas
      South Texas Accelerated Research Therapeutics, LLC
    Jun 21, 2023

    NSCLC Metastatic Trial in La Jolla (Nivolumab + Plinabulin)

    Active, not recruiting
    • Non-small Cell Lung Cancer Metastatic
    • Nivolumab + Plinabulin
    • La Jolla, California
      UC San Diego Moores Cancer Center
    Nov 21, 2022

    NSCLC Metastatic Trial in Shanghai (Almonertinib, SBRT)

    Recruiting
    • Non-small Cell Lung Cancer Metastatic
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Mar 23, 2023

    NSCLC Metastatic Trial in Stockholm (Stereotactic body radiation therapy (SBRT), Temporary Stopping)

    Recruiting
    • Non-small Cell Lung Cancer Metastatic
    • Stereotactic body radiation therapy (SBRT)
    • Temporary Stopping
    • Stockholm, Solna, Sweden
      Karolinska University Hospital
    Nov 9, 2023

    Patients With Advanced Non-Small Cell Lung Cancer

    Completed
    • Non Small Cell Lung Cancer
    • +2 more
      • Indianapolis, Indiana
        Indiana University Melvin & Bren Simon Cancer Center
      Jul 19, 2022

      Non Small Cell Lung Cancer Metastatic Trial (Pembrolizumab in Combination with Plinabulin and Docetaxel)

      Not yet recruiting
      • Non Small Cell Lung Cancer Metastatic
      • Pembrolizumab in Combination with Plinabulin and Docetaxel
      • (no location specified)
      Oct 28, 2022

      Hepatocellular Carcinoma, NSCLC Metastatic, Liver Metastases Trial in Toronto (Atezolizumab, Bevacizumab)

      Recruiting
      • Hepatocellular Carcinoma
      • +2 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Jan 8, 2023

      NSCLC Metastatic Trial in Naestved, Aalborg, Vejle (Circulating tumor DNA treatment monitoring)

      Not yet recruiting
      • Non-small Cell Lung Cancer Metastatic
      • Circulating tumor DNA treatment monitoring
      • Naestved, Zealand, Denmark
      • +2 more
      May 25, 2023

      Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult, KRAS G12C Trial (JDQ443)

      Not yet recruiting
      • Non Small Cell Lung Cancer Metastatic
      • +2 more
      • (no location specified)
      Aug 11, 2023

      NSCLC Metastatic Trial in Chengdu (Camrelizumab, stereotactic body radiation therapy, Chemotherapy)

      Recruiting
      • Non-small Cell Lung Cancer Metastatic
      • Chengdu, Sichuan, China
        Sichuan Cancer Hospital & Institute
      Jul 21, 2022

      NSCLC Metastatic Trial in Seoul (Lazertinib, Tepotinib)

      Not yet recruiting
      • Non-Small Cell Lung Cancer Metastatic
      • Seoul, Gangnam-gu, Korea, Republic of
        Samsung Medical Center
      Oct 27, 2023

      NSCLC Metastatic Trial (bevacizumab plus nab-paclitaxel and platinum)

      Not yet recruiting
      • Non-small Cell Lung Cancer Metastatic
      • bevacizumab plus nab-paclitaxel and platinum
      • (no location specified)
      Jun 2, 2022

      NSCLC Metastatic Trial in Shanghai (Oba01)

      Not yet recruiting
      • Non-small Cell Lung Cancer Metastatic
      • Shanghai, China
        Department of Oncology, Shanghai Lung Cancer Center, Shanghai Ch
      Oct 9, 2023

      Assess Safety and Effectiveness of Zirabev in Domestic Various

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • +7 more
      • (no location specified)
      Jun 30, 2022

      Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)

      Recruiting
      • Metastatic Non-small Cell Lung Cancer (NSCLC)
      • +5 more
      • data collection
      • Oldenburg, Germany
        Pius-Hospital
      Jul 20, 2022

      NSCLC Trial in Guangzhou (BL-M07D1)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Nov 1, 2023

      Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

      Recruiting
      • Non Small Cell Lung Cancer
      • +2 more
      • Port Saint Lucie, Florida
      • +1 more
      Aug 11, 2023

      NSCLC Trial (Tislelizumab IV, Tislelizumab SC, Histology-Based Chemotherapy Doublet)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Tislelizumab IV
      • +2 more
      • (no location specified)
      Oct 25, 2023

      Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)

      Recruiting
      • Non-Small-Cell Lung Cancer
      • Guangzhou, Guangdong, China
        Guangdong General Hospital
      Aug 25, 2023

      NSCLC Trial in Shanghai (SI-B001, SI-B003)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Jul 10, 2023

      NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)

      Not yet recruiting
      • Non-Small Cell Lung Cancer Metastatic
      • (no location specified)
      Jan 18, 2023

      NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Tirelizumab；Chemotherapy monotherapy
      • (no location specified)
      Jul 27, 2023

      Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

      Recruiting
      • Nonsmall Cell Lung Cancer
      • HS-10365 capsules
      • Shanghai, Shanghai, China
        Shanghai Chest Hospital
      Nov 22, 2023